{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:55:50Z","timestamp":1779249350896,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MM Sekhar","award":["Consultancy Project PU"],"award-info":[{"award-number":["Consultancy Project PU"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89594-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T15:56:01Z","timestamp":1740585361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-tumor efficacy and safety of AEV01 in preclinical glioblastoma and hepatocellular carcinoma models"],"prefix":"10.1038","volume":"15","author":[{"given":"Indrani","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilathiban Daisy","family":"Precilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravinda","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Medasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. S.","family":"Anitha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"89594_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40336-022-00489-6","volume":"10","author":"A Pellerino","year":"2022","unstructured":"Pellerino, A., Caccese, M., Padovan, M., Cerretti, G. & Lombardi, G. Epidemiology, risk factors, and prognostic factors of gliomas. Clin. Transl. Imaging 10, 467\u2013475 (2022).","journal-title":"Clin. Transl. Imaging"},{"key":"89594_CR2","doi-asserted-by":"publisher","first-page":"13274","DOI":"10.3390\/ijms241713274","volume":"24","author":"P Coffin","year":"2023","unstructured":"Coffin, P. & He, A. Hepatocellular carcinoma: Past and present challenges and progress in molecular classification and precision oncology. Int. J. Mol. Sci. 24, 13274 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"89594_CR3","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3390\/cancers14133161","volume":"14","author":"NF Brown","year":"2022","unstructured":"Brown, N. F. et al. Survival outcomes and prognostic factors in glioblastoma. Cancers 14, 3161 (2022).","journal-title":"Cancers"},{"key":"89594_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primer 7, 1\u201328 (2021).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"89594_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108631","volume":"257","author":"SM Stribbling","year":"2024","unstructured":"Stribbling, S. M., Beach, C. & Ryan, A. J. Orthotopic and metastatic tumour models in preclinical cancer research. Pharmacol. Ther. 257, 108631 (2024).","journal-title":"Pharmacol. Ther."},{"key":"89594_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s00262-021-02897-5","volume":"70","author":"B Bareham","year":"2021","unstructured":"Bareham, B., Georgakopoulos, N., Matas-C\u00e9spedes, A., Curran, M. & Saeb-Parsy, K. Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies. Cancer Immunol. Immunother. 70, 2737\u20132750 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"89594_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2023.100860","volume":"15","author":"AK Balan","year":"2024","unstructured":"Balan, A. K. et al. A randomized, placebo controlled, double blinded, parallel group clinical study to evaluate the efficacy and safety of AEV01 along with standard care for elderly patients with mild COVID-19. J. Ayurveda Integr. Med. 15, 100860 (2024).","journal-title":"J. Ayurveda Integr. Med."},{"key":"89594_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2174\/1570193X17999201102200944","volume":"18","author":"V Kumar","year":"2021","unstructured":"Kumar, V., Singh, S. B. & Singh, S. Pharmacological perspectives of ayurvedic herbs viz. Alstonia scholaris L., Picrorhiza kurroa, Swertia chirata and Caesalpinia crista against COVID- 19: A mini-review. Mini-Rev. Org. Chem. 18, 841\u2013849 (2021).","journal-title":"Mini-Rev. Org. Chem."},{"key":"89594_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40529-016-0121-2","volume":"57","author":"P Sultan","year":"2016","unstructured":"Sultan, P., Jan, A. & Pervaiz, Q. Phytochemical studies for quantitative estimation of iridoid glycosides in Picrorhiza kurroa Royle. Bot. Stud. 57, 7 (2016).","journal-title":"Bot. Stud."},{"key":"89594_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1055\/s-2006-961542","volume":"58","author":"A Puri","year":"2007","unstructured":"Puri, A. et al. Immunostimulant activity of Picroliv, the Iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters1. Planta Med. 58, 528\u2013532 (2007).","journal-title":"Planta Med."},{"key":"89594_CR11","doi-asserted-by":"publisher","first-page":"107327482110387","DOI":"10.1177\/10732748211038735","volume":"28","author":"P Pi\u00f1a-S\u00e1nchez","year":"2021","unstructured":"Pi\u00f1a-S\u00e1nchez, P. et al. Cancer biology, epidemiology, and treatment in the 21st century: Current status and future challenges from a biomedical perspective. Cancer Control J. Moffitt Cancer Cent. 28, 10732748211038736 (2021).","journal-title":"Cancer Control J. Moffitt Cancer Cent."},{"key":"89594_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/jnci\/djab204","volume":"114","author":"P Brennan","year":"2022","unstructured":"Brennan, P. & Davey-Smith, G. Identifying novel causes of cancers to enhance cancer prevention: New strategies are needed. JNCI J. Natl. Cancer Inst. 114, 353\u2013360 (2022).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"89594_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12032-024-02397-3","volume":"41","author":"D Soni","year":"2024","unstructured":"Soni, D., Wahi, D. & Verma, S. In vitro study on anti-proliferative and anti-cancer activity of picrosides in triple-negative breast cancer. Med. Oncol. 41, 143 (2024).","journal-title":"Med. Oncol."},{"key":"89594_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109494","volume":"120","author":"C Lou","year":"2019","unstructured":"Lou, C. et al. Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo. Biomed. Pharmacother. 120, 109494 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"89594_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.12659\/MSMBR.893327","volume":"21","author":"K Liu","year":"2015","unstructured":"Liu, K., Liu, P., Liu, R. & Wu, X. Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. Med. Sci. Monit. Basic Res. 21, 15\u201320 (2015).","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"89594_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-03596-w","volume":"12","author":"X Luo","year":"2021","unstructured":"Luo, X. et al. The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 12, 1\u201314 (2021).","journal-title":"Cell Death Dis."},{"key":"89594_CR17","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang, P. et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat. Commun. 13, 5782 (2022).","journal-title":"Nat. Commun."},{"key":"89594_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12986-020-0434-8","volume":"17","author":"X Zeng","year":"2020","unstructured":"Zeng, X. et al. Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis. Nutr. Metab. 17, 11 (2020).","journal-title":"Nutr. Metab."},{"key":"89594_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.semcancer.2011.10.005","volume":"21","author":"L-G Larsson","year":"2011","unstructured":"Larsson, L.-G. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin. Cancer Biol. 21, 367\u2013376 (2011).","journal-title":"Semin. Cancer Biol."},{"key":"89594_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120609","volume":"301","author":"S Daisy Precilla","year":"2022","unstructured":"Daisy Precilla, S., Kuduvalli, S. S., Angeline Praveena, E., Thangavel, S. & Anitha, T. S. Integration of synthetic and natural derivatives revives the therapeutic potential of temozolomide against glioma- an in vitro and in vivo perspective. Life Sci. 301, 120609 (2022).","journal-title":"Life Sci."},{"key":"89594_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/fcp.12932","volume":"37","author":"S Daisy Precilla","year":"2023","unstructured":"Daisy Precilla, S. et al. Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma-induced xenograft model by modulating WNT\/\u03b2-catenin signaling. Fundam. Clin. Pharmacol. 37, 1179. https:\/\/doi.org\/10.1111\/fcp.12932 (2023).","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89594-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89594-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89594-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T15:56:06Z","timestamp":1740585366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89594-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89594-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5189060\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that M\/s. Astrel Genome Ltd, India is involved in the current research work, due to their knowledge on the novel product, AEV01. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6980"}}